Jang Ming-kuei
Jang Ming-kuei is the founder of Aprinoia, a transnational biotech company focused on developing innovative diagnostic tools for Alzheimer's disease. His work includes the development of a tau protein imaging agent that aims to visualize tau accumulation in the brain, which is crucial for early detection and treatment planning for Alzheimer's patients.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Taiwan | 1 | 8.00 | 0.12% | +0% | 23,816,775 | 27,791 | $670,000 | 782$ |
| Totals | 1 | 23,816,775 | 27,791 | $670,000 | 782$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Taiwan:
Jang Ming-Kuei, founder and chairman of Aprinoia Therapeutics, presented findings on the diagnostic performance of tau PET imaging.
8
Taiwan:
Jang Ming-kuei, founder of the biotech company Aprinoia, discussed a tau protein imaging agent developed by his company.
6